What is Olutasidenib: Uses, Dosage, Side Effects and More

Olutasidenib is a targeted cancer medication that blocks specific proteins helping cancer cells grow and survive. This oral medication works by inhibiting mutated IDH1 enzymes, which are found in certain blood cancers like acute myeloid leukemia (AML). Your doctor may prescribe this medication when other treatments haven't worked or when your cancer has specific genetic changes that make it a good option for you.

What is Olutasidenib?

Olutasidenib belongs to a class of drugs called IDH1 inhibitors. It specifically targets cancer cells that have mutations in the IDH1 gene, which produces an abnormal enzyme that helps cancer cells grow. Think of it as a very precise tool that goes after cancer cells with this specific weakness while leaving most normal cells alone.

This medication comes as an oral tablet that you take by mouth. The FDA approved olutasidenib specifically for treating relapsed or refractory acute myeloid leukemia in adults who have an IDH1 mutation. Your healthcare team will test your cancer cells to confirm you have this mutation before prescribing this treatment.

What is Olutasidenib Used For?

Olutasidenib treats acute myeloid leukemia (AML) that has come back after treatment or hasn't responded to other therapies. AML is a type of blood cancer where your bone marrow makes too many abnormal white blood cells. These cells crowd out healthy blood cells and can't fight infections properly.

Your doctor will only prescribe this medication if your cancer cells have a specific IDH1 mutation. About 6-10% of people with AML have this genetic change. The medication works best when your cancer has this particular target, which is why genetic testing is essential before starting treatment.

This isn't a first-line treatment for most people with AML. Your medical team typically considers it when initial treatments haven't worked or when your cancer has returned after a period of remission.

How Does Olutasidenib Work?

Olutasidenib blocks the abnormal IDH1 enzyme that cancer cells use to survive and multiply. When this enzyme is mutated, it produces a substance called 2-hydroxyglutarate, which interferes with normal cell development and helps cancer cells avoid dying when they should.

By inhibiting this mutated enzyme, olutasidenib helps restore normal cell development processes. This can allow abnormal cells to mature properly or die off as they're supposed to. The medication also helps reduce the production of that harmful substance that was helping the cancer cells survive.

This is considered a moderately strong targeted therapy. It's specifically designed for cancers with IDH1 mutations, making it very effective for the right patients but not useful for cancers without this genetic change.

How Should I Take Olutasidenib?

Take olutasidenib exactly as your doctor prescribes, usually once daily at the same time each day. You can take it with or without food, but try to be consistent with your choice. Swallow the tablets whole with water and don't crush, break, or chew them.

If you have trouble swallowing pills, talk to your healthcare team about strategies that might help. They may suggest taking the medication with certain foods or liquids to make it easier. Never alter the tablets without asking your doctor first.

Your doctor will likely start you on a specific dose and may adjust it based on how you respond and what side effects you experience. They'll monitor your blood work regularly to check how well the treatment is working and watch for any concerning changes.

How Long Should I Take Olutasidenib?

The length of treatment with olutasidenib varies significantly from person to person. Some people may take it for several months, while others might need it for a year or longer. Your doctor will determine the right duration based on how your cancer responds and how well you tolerate the medication.

You'll have regular check-ups and blood tests to monitor your progress. If the medication is working well and you're managing the side effects, your doctor may recommend continuing treatment. If your cancer isn't responding or if you develop serious side effects, they may suggest stopping or switching to a different treatment.

Don't stop taking olutasidenib on your own, even if you feel better. Your cancer might not show obvious symptoms even when it's active, so it's important to follow your doctor's guidance about when to continue or stop treatment.

What Are the Side Effects of Olutasidenib?

Like all cancer medications, olutasidenib can cause side effects, though not everyone experiences them. Most side effects are manageable with proper medical care and monitoring. Your healthcare team will watch for these effects and help you manage them if they occur.

The most common side effects you might experience include fatigue, nausea, diarrhea, and decreased appetite. These typically develop within the first few weeks of treatment and often improve as your body adjusts to the medication.

Some people also experience low blood cell counts, which can increase your risk of infections, bleeding, or feeling weak and tired. Your doctor will monitor your blood work regularly to catch these changes early and adjust your treatment if needed.

Here are the more serious but less common side effects that require immediate medical attention:

• Differentiation syndrome - rapid swelling and fluid retention that can be life-threatening
• Severe liver problems - yellowing of skin or eyes, dark urine, severe abdominal pain
• Heart rhythm problems - irregular heartbeat, chest pain, or fainting
• Severe infections - fever, chills, persistent cough, or unusual weakness
• Tumor lysis syndrome - rapid breakdown of cancer cells causing kidney problems

These serious side effects are rare but can be dangerous if not treated promptly. Contact your healthcare team immediately if you notice any of these symptoms.

Who Should Not Take Olutasidenib?

Olutasidenib isn't suitable for everyone with AML. You shouldn't take this medication if you're allergic to olutasidenib or any of its ingredients. Your doctor will review your medical history and current medications to determine if it's safe for you.

People with severe liver disease may not be good candidates for this treatment. The medication is processed by your liver, so existing liver problems could make it harder for your body to handle the drug safely.

If you have certain heart conditions, especially those affecting your heart rhythm, your doctor will need to evaluate whether the benefits outweigh the risks. Olutasidenib can sometimes affect heart rhythm, which could be dangerous for people with existing heart problems.

Pregnant women should not take olutasidenib as it can harm the developing baby. If you're of childbearing age, you'll need to use effective birth control during treatment and for some time after stopping the medication.

Olutasidenib Brand Names

Olutasidenib is sold under the brand name Rezlidhia. This is the only brand name currently available for this medication. When your doctor prescribes it, they may write either "olutasidenib" or "Rezlidhia" on your prescription.

Since this is a relatively new medication, there are no generic versions available yet. You'll receive the brand-name version from the pharmaceutical company that developed it.

Olutasidenib Alternatives

If olutasidenib isn't right for you or stops working, your doctor has other treatment options available. The choice depends on your specific situation, including your cancer's characteristics, your overall health, and previous treatments you've received.

Other IDH inhibitors like ivosidenib might be an option if your cancer has a different type of IDH mutation. For people with IDH2 mutations, enasidenib is another targeted therapy that works similarly to olutasidenib.

Your doctor might also consider traditional chemotherapy, other targeted therapies, or newer immunotherapy options. In some cases, a bone marrow transplant might be the best approach. The key is finding the treatment that gives you the best chance of controlling your cancer while maintaining your quality of life.

Is Olutasidenib Better Than Ivosidenib?

Both olutasidenib and ivosidenib are IDH1 inhibitors used to treat AML, but they're not exactly the same. Olutasidenib is newer and was designed to be more potent and selective than ivosidenib. Early studies suggest it may be more effective at blocking the mutated IDH1 enzyme.

However, "better" depends on your individual situation. Some people may respond better to one medication than the other, and the side effect profiles can vary between individuals. Your doctor will consider factors like your previous treatments, overall health, and how your cancer has behaved when choosing between these options.

Both medications have shown promise in clinical trials, but olutasidenib is still being studied in larger groups of patients. Your healthcare team will help you understand which option might work best for your specific case.